Health
textual image stating 'Department of Health, Victoria, Australia'

History of vaccine introduction

Timeline

A timeline detailing the introduction of various vaccines in Australia and more recently specifically for Victoria.

Year (Month) Vaccine details
1804 Small Pox from England
1917 Small Pox produced in Australia
1917 Tetanus antitoxin for Armed Forces
1924 Diphtheria toxin - antitoxin Melbourne City Council
1925 Tetanus toxoid
1925 Pertussis toxoid used in case contacts and epidemics
1927 Diphtheria toxoid
1932 Community immunisation for the public
1945 June Tetanus toxoid available for civilians after World War 2
1953 Diphtheria/Tetanus/Pertussis
1956 May SALK (polio)
1966 September Polio Sabin (OPV)
1969 Measles
1971 February Rubella
1980 Small Pox Vaccination ceased
1981 July Mumps
1982 Pneumovax 14 commenced
1983 February Measles/Mumps
1983 March Hepatitis B Vax (Plasma)
1984/85 End of BCG School Program
1986 CDT-DTP 4th Dose (1st Pertussis booster)
1987 Infants 'at risk' commenced birth dose hepatitis B
1987 Pneumovax 23 commenced
1987 November Hepatitis B Vax ll (Recombinant)
1989 June Measles/Mumps/Rubella (MMR)
1992 May Haemophilus Influenzae (Hib) (18/12 - 5)
1993 July Hib (2/12 - 18/12)
1993 July Hepatitis A (Havrix)
1994 MMR males/females Grade 6
1995 CDT-DTP 5th Dose (2nd Pertussis booster)
1997 Influenza program for over 65's
1997 October Infanrix replaces 4th and 5th dose Triple Antigen

HibTITER Multidose expired (contained thiomersal)
1998 Pneumococcal Pneumonia (over 65's)
1998 MMR Primary School Program
1998 4 year old booster DTP, MMR,OPV program prior to school
1998 Hepatitis B Paediatric vaccine (3 doses) Year 7 secondary school program introduced
1999 MMR 18 to 30 year old campaign
1999 Infanrix - 2/12 to 4 years of age inclusive
2000 May Hepatitis B Birth dose introduced
2000 Comvax (hib-hepatitis B)
2000 OPV ceased in Year 9/10 school Program
2000 Hepatitis B boosters ceased
2000 ADT boosters 10 yearly ceased
2001 Hepatitis B Adult vaccine (2 doses) Year 7 school program
2001 Hepatitis B vaccine for injecting drug users
2001 Varicella (Chickenpox) (unfunded)
2001 Childhood Pneumococcal Pneumonia - Aboriginal and Torres Strait Islander children only
2001 December Meningitec - Meningococcal C conjugate vaccine (unfunded)
2001 Hib TITER vaccine ceased (only Pedvax available)
2002 August NeisVac C - Meningococcal C conjugate vaccine (unfunded)
2002 October Menjugate - Meningococcal C conjugate vaccine (unfunded)
2003 January Meningococcal C conjugate vaccine at 12 months of age
2003 January 1-19 yrs Meningococcal C conjugate vaccination program (till 2006)
2003 September 18th month dose DTPa ceased
Expanded medical risk group for childhood pneumococcal under 5 years of age
2004 January dTpa (Boostrix) for 15-17 years (Year 10 school program) in place of ADT
2004 September 4, 5 and 6 antigen combination vaccines
2005 January Pneumococcal vaccine - Prevenar scheduled at 2, 4 and 6 months of age - catch up in 2005 for children born between 1 January 2003 and 31 December 2004.
2005 January Pneumococcal vaccine - Pneumovax 23 now funded by Federal Government for adults over 65 years of age
2005 November Inactivated Polio Vaccine in combination with diphtheria, tetanus and pertussis scheduled at 2, 4 and 6 months and 4 years of age.
2005 November Oral Polio (Sabin) ceased at 2, 4 and 6 months and 4 years of age.
2005 November Chickenpox (varicella) vaccine scheduled at 18 months of age and for children in Year 7 of secondary school who have not had chickenpox vaccine or the disease.
2007 Hepatitis B vaccine for household contacts of a person living with hepatitis B
2007 Hepatitis B vaccine for prisoners
2007 April Human papillomavirus vaccine for girls aged between 12 and 13 in Year 7 of secondary school. A 2 year catch-up period to the end of June 2009 for girls aged 14 to 18.
2007 July Human papillomavirus vaccine for young women aged between 18 and 26 for a 2 year period to the end of June 2009.
2007 July Rotavirus (RotaTeq) vaccine scheduled at 2, 4 and 6 months of age.
2008 March Diphtheria,tetanus, acellular pertussis, hepatitis B, poliomyelitis and haemophilus influenzae type b (Infanrix hexa) combination vaccine for babies at 2, 4 and 6 months of age.
2008 September Hiberix vaccine (haemophilus influenzae type b) given at 12 months of age for an infant who has at minimum received Infanrix hexa vaccine at six months of age and is up to date with all vaccines.
2008 September Pedvax HIB ceased
2009 June Diphtheria, Tetanus, Pertussis (Boostrix®) Free vaccine for parents with an infant born from 15 June 2009. Program ends 30 June 2012.
2009 September Pandemic influenza Panvax® H1N1 vaccine for people aged 10 years and over.
2009 December Panvax® H1N1 approved for children aged 6 months to under 10 years of age.
2009 December Human papillomavirus (HPV) vaccine (Gardasil®) catch up program for females between 13 and 26 years of age ends 31 December 2009.
2010 Hepatitis B vaccine for people living with HIV
2010 January Human papillomavirus (HPV) vaccine (Gardasil®) Year 7 secondary school girl program or age equivalent.
2010 January Influenza. Expanded eligibility for free seasonal influenza vaccine to include - pregnant women, Indigenous people from 15 years of age and over, residents of nursing homes and other long term care facilities, all people from six months of age and over with conditions predisposing to severe influenza.
2010 December Panvax® H1N1 vaccine program ends on 31 December 2010
2011 July Prevenar® vaccine ceased for use at 2, 4 and 6 months of age.
2011 July Prevenar 13® introduced for the primary schedule at 2, 4 and 6 months of age.
2011 October A supplementary catch-up dose of Prevenar 13® for all children aged 12 months to 35 months. Program ends 30 September 2012
2012 February Hepatitis B vaccine for people living with Hepatitis C
2012 30 June Cessation of Diphtheria, Tetanus, Pertussis (Boostrix®) Free vaccine for parents with an infant born from 15 June 2009.
2012 30 September Cessation of a supplementary catch-up dose of Prevenar 13® for all children aged 12 months to 35 months
2013 January Introduction of the Human papillomavirus vaccine (Gardasil®) for secondary school boys in Year 7 as an on-going program and a 2 year time-limited program for boys in Year 9 in 2013 and 2014.
2013 July Introduction of the measles, mumps, rubella, varicella (MMRV) vaccine (Priorix-Tetra®). MMRV replaces the monovalent varicella vaccine (Varilrix®) at 18 months of age.
2013 July Introduction of the Haemophilus influenzae type b and meningococcal C (Hib-MenC) vaccine (Menitorix®). Hib-MenC vaccine replaces the Haemophilus influenzae type b vaccine Hiberix® and the meningococcal C vaccine NeisVac C® given at 12 months of age.
2013 July Introduction of an alternative measles, mumps and rubella (MMR) vaccine M-M-R-II®. Either Priorix® or M-M-R® II brand can be used for 12-month-old or four-year-old children.
2013 July Introduction of an alternative varicella (chickenpox) vaccine (Varivax®). Either Varilrix® or Varivax® brand can be used for adolescents according to the schedule.
2013 31 December Cessation of the secondary school Year 7 and age equivalent Hepatitis B vaccine catch-up program
2014 January

Expanded Hepatitis B vaccine program for at risk groups

  • household contacts and sexual partners of people living with Hepatitis B
  • people who inject drugs or are on opioid substitution therapy
  • people living with Hepatitis C
  • men who have sex with men
  • people living with HIV
  • prisoners and remandees
2015 January Cessation of the Human papillomavirus vaccine (Gardasil®) for secondary school Year 9 boys (aged 14 to 15 years) 2 year time-limited program in 2013 and 2014.
2015 January

The Boostrix® (diphtheria-tetanus-pertussis) vaccine transitions from Year 10 to Year 7 of secondary school. Adolescents in Years 7, 8, 9 and 10 or aged 12 to 16 years are offered the Boostrix® vaccine.